Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity.

Parry DM, Eldridge R, Kaiser-Kupfer MI, Bouzas EA, Pikus A, Patronas N.

Am J Med Genet. 1994 Oct 1;52(4):450-61.

PMID:
7747758
2.

Neurofibromatosis 2 in the pediatric age group.

Mautner VF, Tatagiba M, Guthoff R, Samii M, Pulst SM.

Neurosurgery. 1993 Jul;33(1):92-6.

PMID:
8355853
3.

Presymptomatic diagnosis of neurofibromatosis 2 using linked genetic markers, neuroimaging, and ocular examinations.

Baser ME, Mautner VF, Ragge NK, Nechiporuk A, Riccardi VM, Klein J, Sainz J, Pulst SM.

Neurology. 1996 Nov;47(5):1269-77.

PMID:
8909442
4.

Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.

Ruggieri M, Iannetti P, Polizzi A, La Mantia I, Spalice A, Giliberto O, Platania N, Gabriele AL, Albanese V, Pavone L.

Neuropediatrics. 2005 Feb;36(1):21-34.

PMID:
15776319
6.

Presymptomatic DNA and MRI diagnosis of neurofibromatosis 2 with mild clinical course in an extended pedigree.

Sainio M, Strachan T, Blomstedt G, Salonen O, Setälä K, Palotie A, Palo J, Pyykkö I, Peltonen L, Jääskeläinen J.

Neurology. 1995 Jul;45(7):1314-22.

PMID:
7617190
7.

Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas.

Antinheimo J, Sankila R, Carpén O, Pukkala E, Sainio M, Jääskeläinen J.

Neurology. 2000 Jan 11;54(1):71-6.

PMID:
10636128
8.

The neuroimaging and clinical spectrum of neurofibromatosis 2.

Mautner VF, Lindenau M, Baser ME, Hazim W, Tatagiba M, Haase W, Samii M, Wais R, Pulst SM.

Neurosurgery. 1996 May;38(5):880-5; discussion 885-6.

PMID:
8727812
9.

Distribution of nonvestibular cranial nerve schwannomas in neurofibromatosis 2.

Fisher LM, Doherty JK, Lev MH, Slattery WH 3rd.

Otol Neurotol. 2007 Dec;28(8):1083-90. Erratum in: Otol Neurotol. 2008 Sep;29(6):885.

PMID:
18043434
10.

Phenotypic variability in monozygotic twins with neurofibromatosis 2.

Baser ME, Ragge NK, Riccardi VM, Janus T, Gantz B, Pulst SM.

Am J Med Genet. 1996 Sep 6;64(4):563-7.

PMID:
8870923
11.

Spinal and cutaneous schwannomatosis is a variant form of type 2 neurofibromatosis: a clinical and molecular study.

Evans DG, Mason S, Huson SM, Ponder M, Harding AE, Strachan T.

J Neurol Neurosurg Psychiatry. 1997 Apr;62(4):361-6.

12.

Ocular abnormalities in neurofibromatosis 2.

Ragge NK, Baser ME, Klein J, Nechiporuk A, Sainz J, Pulst SM, Riccardi VM.

Am J Ophthalmol. 1995 Nov;120(5):634-41.

PMID:
7485365
13.

A clinical, genetic and audiological study of patients and families with unilateral vestibular schwannomas. I. Clinical features of neurofibromatosis in patients with unilateral vestibular schwannomas.

Neary WJ, Newton VE, Laoide-Kemp SN, Ramsden RT, Griffith G, Evans DG, Harris R, Strachan T.

J Laryngol Otol. 1996 Jul;110(7):634-40.

PMID:
8759535
14.

Phenotypic variability associated with 14 splice-site mutations in the NF2 gene.

Kluwe L, MacCollin M, Tatagiba M, Thomas S, Hazim W, Haase W, Mautner VF.

Am J Med Genet. 1998 May 18;77(3):228-33.

PMID:
9605590
15.

Neurofibromatosis type 2 in an infant with multiple plexiform schwannomas as first symptom.

Miyakawa T, Kamada N, Kobayashi T, Hirano K, Fujii K, Sasahara Y, Nagai Y, Shinkai H.

J Dermatol. 2007 Jan;34(1):60-4.

PMID:
17204104
16.

Ophthalmologic findings and long-term course in patients with neurofibromatosis type 2.

Bosch MM, Boltshauser E, Harpes P, Landau K.

Am J Ophthalmol. 2006 Jun;141(6):1068-1077.

PMID:
16765675
17.

Paediatric presentation of type 2 neurofibromatosis.

Evans DG, Birch JM, Ramsden RT.

Arch Dis Child. 1999 Dec;81(6):496-9.

18.

Infantile onset neurofibromatosis type 2 presenting with peripheral facial palsy, skin patches, retinal hamartoma and foot drop.

Tibussek D, Hübsch S, Berger K, Schaper J, Rosenbaum T, Mayatepek E.

Klin Padiatr. 2009 Jul-Aug;221(4):247-50. doi: 10.1055/s-0028-1112155.

PMID:
19629903
19.

Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.

Ng HK, Lau KM, Tse JY, Lo KW, Wong JH, Poon WS, Huang DP.

Neurosurgery. 1995 Oct;37(4):764-73.

PMID:
8559307
20.

Neurofibromatosis type 2 with multiple primary brain tumors in monozygotic twins.

Harada H, Kumon Y, Hatta N, Sakaki S, Ohta S.

Surg Neurol. 1999 May;51(5):528-35. Review.

PMID:
10321884

Supplemental Content

Support Center